Literature DB >> 24649330

Local recurrence of hepatocellular carcinoma in the tumor blood drainage area following radiofrequency ablation.

Masashi Hirooka1, Hironori Ochi1, Yohei Koizumi1, Yoshio Tokumoto1, Atsushi Hiraoka2, Teru Kumagi1, Masanori Abe1, Hiroaki Tanaka3, Yoichi Hiasa1.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. HCC is generally considered to spread via the bloodstream and local recurrence often occurs in the blood drainage area determined by computed tomography during hepatic arteriography (CTHA), despite complete ablation of the primary nodule. This study was conducted in order to prospectively assess the rate of local recurrence in the blood drainage area depicted by delayed-phase CTHA. The participants comprised 364 consecutive patients (260 men and 104 women; mean age, 67.4±8.6 years), enrolled between April, 2002 and December, 2011. The participants were divided into two groups, according to whether the ablation area covered the entire blood drainage area as defined by delayed-phase CTHA (group A) or not (group B). Local tumor progression was compared between the two groups. The median time to recurrence was significantly shorter for group B (434 days) compared to that for group A (1,474 days; P=0.0037). The cumulative local recurrence rates for group A were 0, 0 and 1.5% at 1, 3 and 5 years postoperatively, respectively, whereas the recurrence rates for group B were 3.8, 17.0 and 22.8% at 1, 3 and 5 years, respectively (P<0.0001). In conclusion, the safety margin for radiofrequency ablation should be defined as the blood drainage area and ablation should aim at acquiring adequate safety margins.

Entities:  

Keywords:  blood drainage area; hepatocellular carcinoma; local recurrence; radiofrequency ablation

Year:  2013        PMID: 24649330      PMCID: PMC3917773          DOI: 10.3892/mco.2013.229

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  25 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results.

Authors:  Seong Hyun Kim; Hyo K Lim; Dongil Choi; Won Jae Lee; Seung Hoon Kim; Min Ju Kim; Chan Kyo Kim; Yong Hwan Jeon; Jong Mee Lee; Hyunchul Rhim
Journal:  AJR Am J Roentgenol       Date:  2006-05       Impact factor: 3.959

Review 3.  Local ablation therapy for hepatocellular carcinoma: current status and future perspectives.

Authors:  Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

4.  Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography.

Authors:  Masashi Hirooka; Hidehito Iuchi; Teru Kumagi; Shuichiro Shigematsu; Atsushi Hiraoka; Takahide Uehara; Kiyotaka Kurose; Norio Horiike; Morikazu Onji
Journal:  AJR Am J Roentgenol       Date:  2006-05       Impact factor: 3.959

5.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Authors:  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

6.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.

Authors:  Takahide Nakazawa; Shigehiro Kokubu; Akitaka Shibuya; Koji Ono; Masaaki Watanabe; Hisashi Hidaka; Takeshi Tsuchihashi; Katsunori Saigenji
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

7.  Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.

Authors:  Yasuji Komorizono; Makoto Oketani; Katsumi Sako; Naruhiro Yamasaki; Toshihiko Shibatou; Masahiko Maeda; Kazunori Kohara; Shuhou Shigenobu; Kazuaki Ishibashi; Terukatsu Arima
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

8.  Report of the 15th follow-up survey of primary liver cancer.

Authors:  Iwao Ikai; Yuji Itai; Kiwamu Okita; Masao Omata; Masamichi Kojiro; Kenichi Kobayashi; Yasuni Nakanuma; Shunji Futagawa; Masatoshi Makuuchi; Yoshio Yamaoka
Journal:  Hepatol Res       Date:  2004-01       Impact factor: 4.288

9.  Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Yasuni Nakanuma
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

10.  Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites.

Authors:  Takahide Uehara; Masashi Hirooka; Kiyotaka Ishida; Atsushi Hiraoka; Teru Kumagi; Yoshiyasu Kisaka; Yoichi Hiasa; Morikazu Onji
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

View more
  8 in total

1.  Short-Term Results of Laparoscopic Radiofrequency Ablation Using a Multipolar System for Localized Hepatocellular Carcinoma.

Authors:  Naoki Morimoto; Norio Isoda; Yoshinari Takaoka; Takuya Hirosawa; Shunji Watanabe; Toshiya Otake; Kozue Murayama; Takeshi Fujieda; Mamiko Tsukui; Natsumi Miyata; Kohei Ono; Shota Yamaguchi; Hironori Yamamoto
Journal:  Liver Cancer       Date:  2016-12-17       Impact factor: 11.740

2.  Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm.

Authors:  Toru Ishikawa; Michitaka Imai; Masayoshi Ko; Hiroki Sato; Yujiro Nozawa; Tomoe Sano; Akito Iwanaga; Keiichi Seki; Terasu Honma; Toshiaki Yoshida
Journal:  Mol Clin Oncol       Date:  2017-05-11

3.  Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.

Authors:  Kai Li; Zhongzhen Su; Erjiao Xu; Qiannan Huang; Qingjing Zeng; Rongqin Zheng
Journal:  BMC Cancer       Date:  2017-01-19       Impact factor: 4.430

4.  Iodine-125 Brachytherapy Prophylaxis after Radiofrequency Ablation Cannot Benefit Patients in High Risk of Locoregional Hepatocellular Carcinoma Recurrence.

Authors:  Jian-Fei Tu; Ya-Hui Ding; Li Chen; Xi-Hui Ying; Deng-Ke Zhang; Fa-Zong Wu; Zhong-Wei Zhao; Jian-Song Ji; Wang-Gang Zhang; Hai Zou
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

5.  Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization.

Authors:  Yanqiao Ren; Xiangjun Dong; Lei Chen; Tao Sun; Osamah Alwalid; Xuefeng Kan; Yangbo Su; Bin Xiong; Huimin Liang; Chuansheng Zheng; Ping Han
Journal:  Front Oncol       Date:  2021-03-02       Impact factor: 6.244

6.  An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study.

Authors:  Feng-Yao Li; Jian-Guo Li; Song-Song Wu; Huo-Lin Ye; Xu-Qi He; Qing-Jing Zeng; Rong-Qin Zheng; Chao An; Kai Li
Journal:  J Hepatocell Carcinoma       Date:  2021-11-15

7.  Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular Carcinoma.

Authors:  Masashi Hirooka; Yohei Koizumi; Takaaki Tanaka; Kotarou Sunago; Yoshiko Nakamura; Takao Watanabe; Osamu Yoshida; Yoshio Tokumoto; Masanori Abe; Yoichi Hiasa
Journal:  Hepatol Commun       Date:  2021-03-16

8.  Comparison of local recurrence in transcatheter arterial chemoembolization of hepatocellular carcinoma with or without accumulation of iodized oil beyond corona enhancement area: Short-term results.

Authors:  Yukinobu Watanabe; Masahiro Ogawa; Masahiro Kaneko; Mariko Kumagawa; Midori Hirayama; Naoki Matsumoto; Hiroshi Nakagawara; Toshiki Yamamoto; Mitsuhiko Moriyama
Journal:  Radiol Oncol       Date:  2021-12-22       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.